Ovation iX Iliac Stent Graft TV-IL1422140-JRecalls & reported problems
Endologix LLC · The Ovation iX™ Iliac Limbs are components of the Ovation Prime, Ovation iX, and Alto™ Abdominal Stent Graft Systems. The Ovation iX™ Iliac Limbs are comprised of a nitinol stent encapsulated in low-permeability PTFE. The iliac limbs are deployed into the leg sections of the aortic body. Additional iliac limbs may be used to extend the length of the device, where indicated. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00850007370343), received between Dec 16, 2021 and Dec 26, 2024 — classified as 4 injuries.
The most frequently reported specific device problem is “Off-Label Use” (3 reports).
3 other recalls cover devices cleared under the same FDA submission (P120006); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Off-Label Use3
- Insufficient Device Problem Information1
- Lack of Effect1
- Migration1
- Migration or Expulsion of Device1
- Unintended Movement1
Patient problems
- Aneurysm2
- Clinical Endoleak2
- Failure of Implant1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryDec 26, 2024Off-Label Use; Lack of Effect; Off-Label Use; Lack of Effect
THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2021, WITH THE IMPLANTATION OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM. ON (B)(6) 2024, THE PATIENT UNDERWENT A REINTERVENTION TO ADDRESS A LOST SEAL IN A DILATED RIGHT COMMON ILIAC ARTERY. THE PROCEDURE INVOLVED COILING THE RIGHT HYPOGASTRIC ARTERY AND EXTENDING A 14 MM DIAMETER OVATION LIMB INTO THE EXTERNAL ILIAC ARTERY. THE OPERATION WAS SUCCESSFUL, AND THE PATIENT IS EXPECTED TO BE DISCHARGED THE FOLLOWING MORNING.
Patient problems: Aneurysm; Clinical Endoleak
MAUDE report 21020036 ↗InjuryMay 19, 2023Off-Label Use; Unintended Movement; Off-Label Use; Unintended Movement
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY EIGHT (8) DAYS POST INITIAL PROCEDURE, THE PATIENT PRESENTED IN THE OPERATING ROOM AND THE LEFT OVATION IX ILIAC LIMB WAS FOUND TO HAVE PULLED INTO THE ANEURYSM SAC. A TYPE 1B ENDOLEAK WAS IDENTIFIED. THE PHYSICIAN ELECTED TO IMPLANT A 14X160MM OVATION LIMB IN THE LEFT ILIAC EXTENDING TO THE LEFT EXTERNAL ILIAC ARTERY, 4CM PAST THE LEFT HYPOGASTRIC ARTERY TO SEAL THE ANEURYSM AND ILIACS AND RESOLVE THIS EVENT. THE PATIENT WAS REPORTED AS DOING WELL AND WAS DISCHARGED THE NEXT DAY.
Patient problems: Clinical Endoleak
MAUDE report 16970420 ↗InjuryApr 7, 2022Migration or Expulsion of Device; Off-Label Use; Insufficient Device Problem Information; Migration or Expulsion of Device; Off-Label Use; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH IMPLANT OF THE ALTO ABDOMINAL AORTIC ANEURYSM STENT SYSTEM. APPROXIMATELY ONE (1) YEAR POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH AN ENLARGED COMMON ILIAC ARTERY (UNKNOWN DIAMETER) BUT NO VISIBLE ENDOLEAK. THE PHYSICIAN PLANS TO RE-INTERVENE, AND PATIENT IS REPORTEDLY IN STABLE CONDITION.
Patient problems: Aneurysm
MAUDE report 14047801 ↗InjuryDec 16, 2021Migration; Migration
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY ONE AND A HALF (1.5) MONTHS POST INITIAL PROCEDURE ONE OF THE OVATION LIMBS WAS FOUND TO HAVE MIGRATED PROXIMALLY AND RESULTED IN A TYPE 3A ENDOLEAK. THE PHYSICIAN ELECTED TO COIL THE RIGHT HYPOGASTRIC ARTERY AND EXTENDED WITH TWO (2) OVATION IX ILIAC LIMBS, A 14X160 AND A 14X120 TO RESOLVE THIS EVENT. THE PATIENT STATUS WAS NOT REPORTED.
Patient problems: Failure of Implant
MAUDE report 13019506 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P120006. One submission often covers many models, so check the product and lot details in each record.
- Z-2263-2020 · May 6, 2020 · TerminatedOvation iX Abdominal Stent Graft Systems, REF: TV-AB2080-I, TV-AB2080-J, TV-AB2380-I, TV-AB2380-J, TV-AB2680-I, TV-AB2680-J, TV-AB2980-I, TV-AB2980-J, TV-AB3480-I, TV-AB3480-J
- Z-0125-2015 · Sep 20, 2014 · TerminatedOvation Prime Abdominal Stent Graft System - 29mm Aortic Body stent grafts. The TriVascular Ovation Prime Abdominal Stent Graft System is a low-profile endovascular device deliver
- Z-0288-2013 · Oct 19, 2012 · TerminatedTriVascular brand Fill Polymer Kit, Endovascular Graft, Aneurysm Treatment System, European Model Number: TVFP14-B, (in European distributor inventory only); PRODUCT Usage: The
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page